- Investing Ideas
- /
- Hong Kong Biotech Stocks
Hong Kong Biotech Stocks
Results
64
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
64 companies
WuXi Biologics (Cayman)
Market Cap: HK$100.3b
An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.
2269
HK$24.70
7D
3.8%
1Y
87.7%
Innovent Biologics
Market Cap: HK$92.2b
A biopharmaceutical company, develops, manufactures and commercializes monoclonal antibodies and other drug assets in the fields of oncology, ophthalmology, autoimmune, and cardiovascular and metabolic diseases in China.
1801
HK$55.90
7D
11.6%
1Y
47.1%
Akeso
Market Cap: HK$78.9b
A biopharmaceutical company, engages in the research, development, manufacturing, and commercialization of antibody drugs.
9926
HK$87.90
7D
7.3%
1Y
85.8%
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$75.0b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.
6990
HK$336.80
7D
7.5%
1Y
86.1%
Sino Biopharmaceutical
Market Cap: HK$75.0b
An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.
1177
HK$4.19
7D
4.8%
1Y
42.5%
CSPC Pharmaceutical Group
Market Cap: HK$74.5b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$6.52
7D
13.2%
1Y
0.2%
3SBio
Market Cap: HK$49.2b
An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.
1530
HK$20.85
7D
80.4%
1Y
230.4%
WuXi XDC Cayman
Market Cap: HK$46.1b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$38.35
7D
-0.4%
1Y
141.5%
China Resources Pharmaceutical Group
Market Cap: HK$32.2b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$5.12
7D
3.4%
1Y
-15.5%
Grand Pharmaceutical Group
Market Cap: HK$29.6b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$8.45
7D
8.3%
1Y
74.6%
Shanghai Junshi Biosciences
Market Cap: HK$29.1b
A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China.
1877
HK$16.94
7D
15.1%
1Y
34.4%
United Laboratories International Holdings
Market Cap: HK$24.9b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$13.68
7D
5.2%
1Y
44.3%
Genscript Biotech
Market Cap: HK$23.7b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$10.94
7D
3.8%
1Y
-4.0%
Shanghai Henlius Biotech
Market Cap: HK$23.6b
Engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases.
2696
HK$43.50
7D
14.8%
1Y
130.9%
InnoCare Pharma
Market Cap: HK$23.2b
A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.
9969
HK$10.98
7D
16.8%
1Y
122.3%
China Medical System Holdings
Market Cap: HK$21.3b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$8.80
7D
6.5%
1Y
29.8%
Duality Biotherapeutics
Market Cap: HK$17.2b
Duality Biotherapeutics Inc., a clinical-stage biotech company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others.
9606
HK$195.00
7D
4.8%
1Y
n/a
Everest Medicines
Market Cap: HK$14.8b
A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.
1952
HK$45.60
7D
-0.3%
1Y
92.0%
CanSino Biologics
Market Cap: HK$12.1b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$35.35
7D
11.0%
1Y
65.6%
Shanghai Haohai Biological Technology
Market Cap: HK$11.8b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$25.75
7D
9.6%
1Y
-16.6%
YiChang HEC ChangJiang Pharmaceutical
Market Cap: HK$11.7b
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
1558
HK$13.26
7D
1.4%
1Y
28.0%
Keymed Biosciences
Market Cap: HK$11.6b
A biotechnology company, focuses on in-house discovery and development of biological therapies in the autoimmune and oncology therapeutic areas.
2162
HK$42.20
7D
4.7%
1Y
16.6%
China Traditional Chinese Medicine Holdings
Market Cap: HK$10.8b
China Traditional Chinese Medicine Holdings Co.
570
HK$2.15
7D
1.4%
1Y
-49.5%
Shandong Xinhua Pharmaceutical
Market Cap: HK$9.7b
Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.
719
HK$6.05
7D
6.3%
1Y
5.6%
SSY Group
Market Cap: HK$8.7b
An investment holding company, research, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$2.94
7D
1.4%
1Y
-38.1%
Alphamab Oncology
Market Cap: HK$8.6b
A clinical stage biopharmaceutical company, engages in the research, development, manufacture, and commercialization of oncology biologics.
9966
HK$8.98
7D
35.9%
1Y
83.3%
Consun Pharmaceutical Group
Market Cap: HK$8.2b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$9.90
7D
5.3%
1Y
44.7%
HBM Holdings
Market Cap: HK$7.7b
A clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel antibody therapeutics in immunology and oncology disease areas.
2142
HK$9.70
7D
8.4%
1Y
592.9%
Ascletis Pharma
Market Cap: HK$6.7b
A biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China.
1672
HK$7.00
7D
20.1%
1Y
426.3%
Tong Ren Tang Technologies
Market Cap: HK$6.6b
Produces and distributes of Chinese medicine products in Mainland China and Hong Kong.
1666
HK$5.12
7D
2.4%
1Y
-11.3%
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$5.7b
A biotechnology company, engages in the research and development of antibody-based drugs in the People’s Republic of China, the United States, and internationally.
2315
HK$14.28
7D
19.2%
1Y
46.8%
China Shineway Pharmaceutical Group
Market Cap: HK$5.6b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$7.42
7D
3.6%
1Y
-19.3%
Abbisko Cayman
Market Cap: HK$5.5b
An investment holding company, engages in the research and development of pharmaceutical products in the People’s Republic of China.
2256
HK$8.81
7D
11.0%
1Y
155.4%
AIM Vaccine
Market Cap: HK$4.4b
Researches, develops, manufactures, and commercializes of vaccine products for human use in the People’s Republic of China.
6660
HK$3.61
7D
8.4%
1Y
-52.5%
Beijing Luzhu Biotechnology
Market Cap: HK$4.3b
A biotechnology company, focuses on the research and development, production, and sale of human vaccines and therapeutic biologics to prevent and control infectious diseases, and treat cancer and autoimmune diseases in China.
2480
HK$21.40
7D
-0.5%
1Y
-12.7%
Viva Biotech Holdings
Market Cap: HK$3.6b
An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.
1873
HK$1.73
7D
4.2%
1Y
137.0%